Phenazone Market contains market size and forecasts of Phenazone (Antipyrine) in Global, including the following market information:
- Global Phenazone (Antipyrine) Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global top five companies in 2021 (%)
The global Phenazone (Antipyrine) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
- The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
- Solution Segment to Reach $ Million by 2028, with a % CAGR in next six years.
- The global key manufacturers of Phenazone (Antipyrine) include Endo, Pfizer, Herbages Naturbec, Bayer, CSPC, Huadong Medicine, Northeast Pharmaceutical, NCPC and Sinopharm, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
- We surveyed the Phenazone (Antipyrine) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Phenazone (Antipyrine) Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Phenazone (Antipyrine) Market Segment Percentages, by Type, 2021 (%)
Global Phenazone (Antipyrine) Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Phenazone (Antipyrine) Market Segment Percentages, by Application, 2021 (%)
- Analytical Reagent for Nitric Acid, Nitrite and Iodine
- Antipyretic And Analgesic
Global Phenazone (Antipyrine) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Phenazone (Antipyrine) Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Phenazone (Antipyrine) revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Phenazone (Antipyrine) revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Endo
- Pfizer
- Herbages Naturbec
- Bayer
- CSPC
- Huadong Medicine
- Northeast Pharmaceutical
- NCPC
- Sinopharm
- Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)
- Tianfang Pharmaceutical
- Tianjin Jinyao Pharmaceutical
- Shandong Huaxin Pharmaceutical Group
- Shandong Xinhua Pharmaceutical
- Shandong Fangming Pharmaceutical Group
- Shanxi Taiyuan Pharmaceutical
- Shanxi Jinxin Shuanghe Pharmaceutical Co. , Ltd.
- Guangdong Sancai Shiqi District Pharmaceutical
- Guangdong Nanguo Pharmaceutical
- Kaifeng Pharmaceutical Group
- Yuekang Pharmaceutical Group Anhui Biopharmaceutical
- Xinxiang Changle Pharmaceutical
- Wuhan Fuxing Biopharmaceutical
- Henan Runhong Pharmaceutical
- Henan Furen Huaiqingtang Pharmaceutical
- Hainan Pharmaceutical Factory
Industry Market Size
